Last checked at 9 Feb 2022 11:01
TOP NEWS SUMMARY: GSK delivers on earnings ahead of consumer spin-off
TOP NEWS SUMMARY: GSK delivers on earnings ahead of consumer spin-off
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat1
GSK Share
Trades5,890
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,654.50
Bid:
1,654.50
Ask:
1,655.00
Change:
14.00 (0.85%)
Spread:
0.50 (0.03%)
Open:
1,638.50
High:
1,655.00
Low:
1,634.00
Prev. Close:
1,640.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.9 Feb 2022 09:36
GLOBAL MARKETS-World stocks firm, bonds win respite from rout
* Stocks rally, bond yields edge off highs* U.S. stock futures higher* Upbeat earnings support sentiment (Changes dateline to London, updates throughout)By Dhara RanasingheLONDON, Feb 9 (Reuters) - World stock markets rallied on Wednesday, putting ...
Read more9 Feb 2022 08:29
GSK Covid sales soar but sees slowdown next year
(Sharecast News) - UK pharmaceutical giant GSK said Covid-related sales hit £1.4bn last year as it reported better-than-expected fourth-quarter earnings.
Read more9 Feb 2022 08:26
TOP NEWS: GSK guides to growth as it readies consumer health split
TOP NEWS: GSK guides to growth as it readies consumer health split
Read more9 Feb 2022 08:21
LONDON BRIEFING: GlaxoSmithKline says on track for consumer demerger
LONDON BRIEFING: GlaxoSmithKline says on track for consumer demerger
Read more9 Feb 2022 07:54
LONDON MARKET PRE-OPEN: Barratt lifts interim payout as results upbeat
LONDON MARKET PRE-OPEN: Barratt lifts interim payout as results upbeat
Read more9 Feb 2022 07:24
UPDATE 4-GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off
* Sotrovimab sales top estimates, but margins set to drop* Consumer healthcare spin off on track* Quarterly results beat forecasts, 2022 sales to grow (Adds analyst comment, details on consumer arm)By Pushkala Aripaka and Ludwig BurgerFeb 9 (Reuters...
Read more9 Feb 2022 07:24
UPDATE 3-GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off
* Sotrovimab sales top estimates, but margins set to drop* Consumer healthcare spin off on track* Quarterly results beat forecasts, 2022 sales to grow (Adds share movement, detail on earnings and forecast, background)By Pushkala Aripaka and Ludwig ...
Read more9 Feb 2022 07:24
UPDATE 2-GSK's COVID-related sales close to $2 bln, profit boost to wane in 2022
* Sotrovimab sales top estimates, but margins set to drop* Consumer healthcare spin off on track* Quarterly results beat forecasts, 2022 sales to grow (Adds detail from statement, background)Feb 9 (Reuters) - GSK racked up 1.4 billion pounds ($1.9 ...
Read more9 Feb 2022 07:24
UPDATE 1-GSK's COVID-related sales close to $2 bln, profit boost to wane in 2022
(Adds details from statement, background)Feb 9 (Reuters) - GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, as it beat quarterly forecasts in its first earnings report since reje...
Read more9 Feb 2022 07:09
GSK logs nearly $2 bln in COVID-related sales, but profit boost to wane in 2022
Feb 9 (Reuters) - GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, as it beat quarterly forecasts in its first earnings report since rejecting a bid from Unilever for its consum...
Read more8 Feb 2022 15:00
Wednesday preview: Fedspeak, GSK in the spotlight
(Sharecast News) - Inverstors' attention on Wednesday will be on appearances by two top US central bank officials, whose words will be carefully parsed for any policy relevant remarks.
Read more7 Feb 2022 14:15
GSK's Viiv Healthcare to release new long-term data for HIV treatments
GSK's Viiv Healthcare to release new long-term data for HIV treatments
Read more4 Feb 2022 07:32
CORRECTED-UPDATE 1-France's Sanofi still sees COVID-19 phase 3 trial completed in Q1
(Corrects headline, bullet point, 1st, 8th and 9th paras to show Sanofi expects its vaccine's phase 3 trial to finish in Q1 (not win approval for vaccine in Q1). Also corrects headline, 1st para to show it did not say vaccine would drive earnings ...
Read more3 Feb 2022 14:36
UPDATE 1-EU watchdog says supports fast development of Omicron-only vaccine
* Monovalent development welcome if it is the fastest option-EMA* EMA continues to prefer research into several vaccine upgrades* Approval of Valneva, Sanofi vaccines before easter not certain (Adds details on vaccine developers)By Ludwig Burger ...
Read more